DIFFERENCES IN KINETIC-PROPERTIES OF PURE RECOMBINANT HUMAN AND MOUSE DEOXYCYTIDINE KINASE

被引:29
作者
JOHANSSON, M [1 ]
KARLSSON, A [1 ]
机构
[1] KAROLINSKA INST,MED NOBEL INST,DEPT MED BIOCHEM & BIOPHYS,S-17177 STOCKHOLM,SWEDEN
关键词
DEOXYCYTIDINE KINASE; NUCLEOSIDE PHOSPHORYLATION; NUCLEOSIDE ANALOGS; NUCLEOSIDE METABOLISM; PYRIMIDINE METABOLISM; PURINE METABOLISM;
D O I
10.1016/0006-2952(95)00129-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Human and mouse deoxycytidine kinase (dCK) (EC 2.7.1.74) were cloned and expressed in Escherichia coli. Michaelis-Menten kinetics were determined for the purified enzymes with 2'-deoxycytidine (dCyd), 2'-deoxyadenosine (dAdo), 2-chloro-2'-deoxyadenosine (CdA), 2',3'-dideoxycytidine (ddCyd) and 9-beta-D-arabinofuranosylguanine (araG) as substrates and ATP and UTP as phosphate donors. Both human and mouse dCK showed highest affinity to dCyd with K-m values of 0.05-0.2 mu M. The anti-leukaemic compound CdA was the superior substrate of the nucleoside analogues tested. Both enzymes were able to efficiently utilize ATP and UTP as phosphate donors. However, the use of UTP instead of ATP as phosphate donor decreased K-m values for all substrates investigated. The kinetic properties of mouse and human dCK differed in that the human enzyme showed higher affinity for the substrates dAdo, CdA, ddCyd and araG. The human enzyme also showed higher affinity for ATP and UTP. The ability to phosphorylate dCyd was, however, similar for both human and mouse dCK. At physiological concentration of the feedback inhibitor dCTP, mouse dCK showed lower activity than human dCK for all substrates investigated.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 18 条
[1]   THE INVITRO AND INVIVO ANTI-RETROVIRUS ACTIVITY, AND INTRACELLULAR METABOLISM OF 3'-AZIDO-2',3'-DIDEOXYTHYMIDINE AND 2',3'-DIDEOXYCYTIDINE ARE HIGHLY DEPENDENT ON THE CELL SPECIES [J].
BALZARINI, J ;
PAUWELS, R ;
BABA, M ;
HERDEWIJN, P ;
DECLERCQ, E ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (05) :897-903
[2]   DEOXYCYTIDINE KINASE FROM HUMAN-LEUKEMIC SPLEEN - PREPARATION AND CHARACTERIZATION OF THE HOMOGENEOUS ENZYME [J].
BOHMAN, C ;
ERIKSSON, S .
BIOCHEMISTRY, 1988, 27 (12) :4258-4265
[3]  
BOHMAN C, 1990, BIOCH LIFE SCI ADV, V9, P11
[4]  
CARSON DA, 1980, J IMMUNOL, V124, P8
[5]   INITIAL STUDIES ON THE CELLULAR PHARMACOLOGY OF 2',3'-DIDEOXYCYTIDINE, AN INHIBITOR OF HTLV-III INFECTIVITY [J].
COONEY, DA ;
DALAL, M ;
MITSUYA, H ;
MCMAHON, JB ;
NADKARNI, M ;
BALZARINI, J ;
BRODER, S ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (13) :2065-2068
[6]  
DATTA NS, 1989, J BIOL CHEM, V264, P9359
[7]   DEOXYNUCLEOSIDE PHOSPHORYLATING ENZYMES IN MONKEY AND HUMAN TISSUES SHOW GREAT SIMILARITIES, WHILE MOUSE DEOXYCYTIDINE KINASE HAS A DIFFERENT SUBSTRATE-SPECIFICITY [J].
HABTEYESUS, A ;
NORDENSKJOLD, A ;
BOHMAN, C ;
ERIKSSON, S .
BIOCHEMICAL PHARMACOLOGY, 1991, 42 (09) :1829-1836
[8]  
IVES DH, 1970, J BIOL CHEM, V245, P2285
[9]   RAPID DETERMINATION OF NUCLEOSIDE KINASE AND NUCLEOTIDASE ACTIVITIES WITH TRITIUM-LABELED SUBSTRATES [J].
IVES, DH ;
DURHAM, JP ;
TUCKER, VS .
ANALYTICAL BIOCHEMISTRY, 1969, 28 (1-3) :192-&
[10]   DIRECT PHOTOAFFINITY-LABELING OF HUMAN DEOXYCYTIDINE KINASE WITH THE FEEDBACK INHIBITOR DCTP [J].
JANSSON, O ;
ERIKSSON, S .
BIOCHEMICAL JOURNAL, 1990, 269 (01) :201-205